Standard review cold-active microbial lipases: a versatile tool for industrial applications B Joseph, PW Ramteke, G Thomas, N Shrivastava Biotechnol Mol Biol Rev 2 (2), 39-48, 2007 | 166 | 2007 |
Artificial intelligence in surveillance, diagnosis, drug discovery and vaccine development against COVID-19 G Arora, J Joshi, RS Mandal, N Shrivastava, R Virmani, T Sethi Pathogens 10 (8), 1048, 2021 | 89 | 2021 |
Extracellular cold-active lipase of Microbacterium luteolum isolated from Gangotri glacier, western Himalaya: Isolation, partial purification and characterization B Joseph, N Shrivastava, PW Ramteke Journal of Genetic Engineering and Biotechnology 10 (1), 137-144, 2012 | 68 | 2012 |
NR2F1 is a barrier to dissemination of early-stage breast cancer cells C Rodriguez-Tirado, N Kale, MJ Carlini, N Shrivastava, AA Rodrigues, ... Cancer research 82 (12), 2313-2326, 2022 | 24 | 2022 |
Palbociclib renders human papilloma virus–negative head and neck squamous cell carcinoma vulnerable to the senolytic agent navitoclax NJ Gadsden, CD Fulcher, D Li, N Shrivastava, C Thomas, JE Segall, ... Molecular Cancer Research 19 (5), 862-873, 2021 | 22 | 2021 |
Prilocaine hydrochloride protects zebrafish from lethal effects of ionizing radiation: role of hematopoietic cell expansion M Dimri, J Joshi, N Shrivastava, S Ghosh, R Chakraborti, PK Indracanti Tokai J Exp Clin Med 40 (1), 8-15, 2015 | 13 | 2015 |
CDK4/6 Inhibition Induces Senescence and Enhances Radiation Response by Disabling DNA Damage Repair in Oral Cavity Squamous Cell Carcinoma † Nitisha Shrivastava 1,2 , Claudia Gutierrez Chavez 2, Daniel Li 3, Vikas ... CANCERS 15 (7), 2023 | 8 | 2023 |
Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods D Li, C Thomas, N Shrivastava, A Gersten, N Gadsden, N Schlecht, ... Journal of medical virology 95 (2), e28388, 2023 | 8 | 2023 |
Cycloxygenase-2 (COX-2)-a potential target for screening of small molecules as radiation countermeasure agents: an in silico study J Joshi, T K. Barik, N Shrivastava, M Dimri, S Ghosh, R S. Mandal, ... Current Computer-Aided Drug Design 9 (1), 35-45, 2013 | 8 | 2013 |
Epigenetic and pluripotency aspects of disseminated cancer cells during minimal residual disease MJ Carlini, N Shrivastava, MS Sosa Biological Mechanisms of Minimal Residual Disease and Systemic Cancer, 1-18, 2018 | 7 | 2018 |
Cyclooxygenase-2 identified as a potential target for novel radiomodulator scopolamine methyl bromide: An in silico study N Shrivastava, J Joshi, N Sehgal, IP Kumar Informatics in Medicine Unlocked 9, 18-25, 2017 | 5 | 2017 |
Ligand and structure based models for the identification of Beta 2 adrenergic receptor antagonists J Joshi, M Dimri, S Ghosh, N Shrivastava, R Chakraborti, N Sehgal, J Ray, ... Current computer-aided drug design 11 (3), 222-236, 2015 | 4 | 2015 |
Characterization of a Diverse Set of Conditionally Reprogrammed Head and Neck Cancer Cell Cultures TJ Ow, V Mehta, D Li, C Thomas, N Shrivastava, N Kawachi, AJ Gersten, ... The Laryngoscope 134 (6), 2748-2756, 2024 | 1 | 2024 |
CDK4/6 inhibition induces senescence and enhances Radiation Response by disabling DNA damage repair in oral cavity squamous cell carcinoma. Cancers (Basel). 2023; 15 N Shrivastava, CG Chavez, D Li, V Mehta, C Thomas, CD Fulcher, ... | 1 | 2023 |
Target based screening of small molecule library identifies pregnelonene, a Nrf2 agonist, as a potential radioprotector in zebrafish J Joshi, S Ghosh, M Dimri, N Shrivastava, PK Indracanti, J Ray | 1 | 2014 |
Scopolamine methylbromide mitigates radiation induced damage and lethality in zebrafish N Shrivastava, J Joshi, S Ghosh, M Dimri, P Kumar, E Indracanti, ... | 1 | 2014 |
Comprehensive functional evaluation of head and neck squamous cell carcinoma with BH3-profiling demonstrates apoptotic competency and therapeutic efficacy of BH3-mimetics D Li, A Lopez, N Shrivastava, W Chan, C Thomas, R Burk, J Segall, ... Oral Oncology 159, 107069, 2024 | | 2024 |
The CDK4/6 inhibitor palbociclib sensitizes oral cavity squamous cell carcinoma to navitoclax-induced apoptosis-An in vitro and in vivo study N Shrivastava, N Kawachi, MB Prystowsky, E Gavathiotis, C Guha, TJ Ow Cancer Research 83 (7_Supplement), 5986-5986, 2023 | | 2023 |
The role of FOXM1 in senescence suppression and radiation resistance in oral cavity squamous cell carcinoma N Shrivastava, Y Wallach, D Li, C Thomas, MB Prystowsky, I Basu, ... Cancer Research 82 (12_Supplement), 203-203, 2022 | | 2022 |
NR2F1 is a barrier to early dissemination of pre-malignant mammary cells MS Sosa, C Rodriguez-Tirado, N Kale, M Carlini, N Shrivastava, B Khalil, ... Cancer Research 81 (13_Supplement), 2837-2837, 2021 | | 2021 |